miRoncol Diagnostics

Ottawa, Canada

miRoncol Health is a healthcare startup that offers the Real-time Multi-Cancer Early Risk Assessment test. This innovative blood-based test detects microRNA signatures, which are biological signals linked to early-stage solid tumors, providing users with insights into their current molecular cancer risk. The service is aimed at health-conscious individuals, those with a family history of cancer, and anyone looking for proactive health insights. Utilizing advanced AI and genomics, miRoncol empowers individuals to engage in informed discussions with their physicians about potential follow-up evaluations, complementing established cancer screening programs. The technology aims to enhance early detection and facilitate better healthcare decisions.